伽玛刀放射外科治疗听神经瘤的长期肿瘤控制率
本研究回顾性分析1995至2015年在南加州大学Keck医院接受伽玛刀放射外科治疗的散发性听神经瘤患者,随访至少12个月;中位随访69个月,肿瘤控制率98.1%,并发症包括听力丧失17.3%、平衡障碍/共济失调加重7.7%和脑积水1.92%。
要点
- 中位随访69个月,51例(98.1%)患者实现肿瘤控制。
- 1例在伽玛刀后22个月出现肿瘤进展,需手术干预并最终缓解。
- 并发症包括听力丧失17.3%、平衡障碍/共济失调加重7.7%、脑积水1.92%。
核心结论
- 散发性听神经瘤患者接受伽玛刀放射外科治疗后,在中位随访时间超过5年的情况下肿瘤控制率高;伽玛刀是治疗经选择的散发性听神经瘤安全有效的方法。
研究设计与样本
- 回顾性综述,纳入1995至2015年在南加州大学Keck医院接受伽玛刀放射外科治疗、随访至少12个月的散发性听神经瘤患者。
主要发现
- 治疗时中位年龄63.7岁(范围19.4-84.2岁),中位随访时间69个月。
- 中位肿瘤直径17.5 mm(范围5.0-29.0 mm),中位治疗体积2.41 cm3(范围0.09-12.8 cm3),中位处方剂量12.50 Gy。
- 随访期间(12-192个月)51例(98.1%)患者实现肿瘤控制。
- 1例患者在伽玛刀放射外科后22个月出现肿瘤进展,需手术干预,最终缓解。
- 并发症包括听力丧失(17.3%)、平衡障碍/共济失调加重(7.7%)和脑积水(1.92%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acoustic neuromas (ANs) are benign intracranial tumors that arise from myelin-forming Schwann cells surrounding the vestibular branch of the vestibulocochlear nerve (cranial nerve VIII). Treatment options for AN include observation, radiosurgery, and microsurgical resection. Gamma Knife radiosurgery (GKRS) for AN has well-documented short-term safety and efficacy for carefully selected patients. Recent innovations in GKRS technology may improve long-term outcomes. The aim of this study was to report long-term tumor control and complication rates after GKRS for sporadic AN. METHODS: A retrospective review was performed of patients with sporadic ANs at Keck Hospital of USC who underwent GKRS from 1995 to 2015 with a minimum follow-up of 12 months. RESULTS: Median age at treatment was 63.7 years (range, 19.4-84.2 years). Median follow-up time was 69 months. Median tumor diameter was 17.5 mm (range, 5.0-29.0 mm), and median treatment volume was 2.41 cm3 (range, 0.09-12.8 cm3). Median prescribed dose was 12.50 Gy. Tumor control was achieved in 51 (98.1%) patients over the follow-up period (12-192 months). One patient experienced tumor progression at 22 months after GKRS, requiring surgical intervention, which ultimately resulted in remission. Complications included hearing loss (17.3%), worsened balance/ataxia (7.7%), and hydrocephalus (1.92%). CONCLUSIONS: Patients undergoing GKRS for sporadic ANs had high rates of tumor control over a median follow-up time of >5 years. Improvements in radiosurgery treatment planning were seen in the most recent cohort of patients. GKRS is a safe and effective modality for treating sporadic ANs in selected patients.
引用
- Tucker DW, Gogia AS, Donoho DA, et al. Long-Term Tumor Control Rates Following Gamma Knife Radiosurgery for Acoustic Neuroma. World Neurosurg. 2018. PMID: 30447465. doi:10.1016/j.wneu.2018.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。